Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis (Q34643194)

3 August 2017

title

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis (English)

1 reference

multidrug-resistant tuberculosis

3 August 2017

0 references

multiple drug resistance

1 reference

1 reference

1 reference

Vija Skripconoka

1 reference

3 August 2017

Manfred Danilovits

1 reference

3 August 2017

Lea Pehme

1 reference

3 August 2017

Tarmo Tomson

1 reference

3 August 2017

Girts Skenders

1 reference

3 August 2017

Tiina Kummik

1 reference

3 August 2017

Andra Cirule

1 reference

3 August 2017

Vaira Leimane

1 reference

3 August 2017

Anu Kurve

1 reference

3 August 2017

Klavdia Levina

1 reference

3 August 2017

Lawrence J Geiter

1 reference

3 August 2017

Davide Manissero

1 reference

3 August 2017

Charles D Wells

1 reference

3 August 2017

publication date

27 September 2012

1 reference

European Respiratory Journal

3 August 2017

published in

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

1393-1400

1 reference

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

Tuberculosis treatment outcome monitoring in European Union countries: systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

Delamanid for multidrug-resistant pulmonary tuberculosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

Tuberculosis: cost of illness in Germany

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

Analysis of tuberculosis treatment outcomes in the European Union and European Economic Area: efforts needed towards optimal case management and control.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

Epidemiology and clinical management of XDR-TB: a systematic review by TBNET.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

Preventing and managing antimicrobial resistance: imperative for chest physicians

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

Declaration of Helsinki. Ethical principles for medical research involving human subjects.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

ICH harmonized tripartite guideline: Guideline for Good Clinical Practice.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3669462

Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome

9 December 2018

1 reference

12 December 2020

Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects

1 reference

12 December 2020

Cost of tuberculosis in the era of multidrug resistance: will it become unaffordable?

1 reference

12 December 2020

Treatment of tuberculosis: have we turned the corner?

1 reference

12 December 2020

Multidrug-resistant tuberculosis

1 reference

12 December 2020

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects

1 reference

12 December 2020

10.1183/09031936.00125812

Identifiers

DOI

1 reference

3 August 2017

1 reference

3 August 2017

1 reference